Published in Arterioscler Thromb Vasc Biol on June 01, 1999
Association of warfarin dose with genes involved in its action and metabolism. Hum Genet (2006) 3.27
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study. Blood (2010) 1.13
PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study. J Thromb Haemost (2008) 1.08
Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study. J Thromb Haemost (2009) 0.91
Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia. Hum Genet (2007) 0.87
Association of common genetic variation in the protein C pathway genes with clinical outcomes in acute respiratory distress syndrome. Crit Care (2016) 0.83
Discovering novel risk factors for venous thrombosis: a candidate-gene approach. Thromb Res (2009) 0.81
Protein C -1641A/-1654C haplotype is associated with organ dysfunction and the fatal outcome of severe sepsis in Chinese Han population. Hum Genet (2008) 0.80
Genetic markers associated with plasma protein C level in African Americans: the atherosclerosis risk in communities (ARIC) study. Genet Epidemiol (2014) 0.78
A genetic risk score comprising known venous thromboembolism loci is associated with chronic venous disease in a multi-ethnic cohort. Thromb Res (2015) 0.77
The SNPs (-1654C/T, -1641A/G and -1476A/T) of protein C promoter are associated with susceptibility to pulmonary thromboembolism in a Chinese population. J Thorac Dis (2014) 0.75
Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension (2001) 11.18
Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension (1997) 3.21
Sequence diversity in 36 candidate genes for cardiovascular disorders. Am J Hum Genet (1999) 3.02
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost (1992) 2.31
Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women. Eur Heart J (2002) 2.30
Management of craniosynostoses. Childs Nerv Syst (2000) 2.27
Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension (1998) 2.20
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care (1997) 2.18
Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism. J Thromb Haemost (2006) 2.17
Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet (1993) 2.06
Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost (1994) 1.96
Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation (1999) 1.90
Otitis media. Clinical observations, microbiology, and evaluation of therapy. Am J Dis Child (1968) 1.81
Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE study. J Thromb Haemost (2005) 1.80
Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass. J Thromb Haemost (2004) 1.79
Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol (1995) 1.76
Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J (1997) 1.76
Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension (1989) 1.72
Functional outcome after surgery for trigonocephaly. Plast Reconstr Surg (1998) 1.71
Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. Hypertension (1999) 1.71
Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study. J Thromb Haemost (2007) 1.67
The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol (1996) 1.64
Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke (2000) 1.62
Interrelationships of viral, mycoplasmal, and bacterial agents in uncomplicated pneumonia. Am Rev Respir Dis (1968) 1.58
Reliability of reported family history of myocardial infarction. BMJ (1993) 1.52
Temporal and geographical trends in indications for implantation of cardiac defibrillators in Europe 1993-1998. Medtronic ICD System Investigators. Pacing Clin Electrophysiol (2000) 1.52
Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases. Eur J Clin Invest (2001) 1.51
New polymorphisms in the interleukin-10 gene--relationships to myocardial infarction. Eur J Clin Invest (2001) 1.50
Percutaneous transluminal angioplasty for emboligenic arterial lesions after radiotherapy of axillary arteries. J Vasc Surg (1995) 1.49
Fibrin glue fixation in forehead endoscopy: evaluation of our experience with 206 cases. Plast Reconstr Surg (1997) 1.48
Correlation between time-domain measures of heart rate variability and scatterplots in postinfarction patients. Pacing Clin Electrophysiol (1996) 1.43
Relationship between alcohol intake, health and social status and cardiovascular risk factors in the Urban Paris-Ile-de-France Cohort: is the cardioprotective action of alcohol a myth? Eur J Clin Nutr (2010) 1.43
Thromboangiitis obliterans (Buerger's disease). Rev Rhum Engl Ed (1997) 1.41
Antiphospholipid antibodies and atherosclerosis. Am J Med (1992) 1.41
Rheumatic manifestations in patients with thromboangiitis obliterans (Buerger's disease). J Rheumatol (1999) 1.40
[Chiari "malformation" in Crouzon syndrome]. Arch Pediatr (1996) 1.39
[Rapid selection that rectifies a diagnosis of arteritis!]. Presse Med (2000) 1.39
Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell lines. J Lab Clin Med (1996) 1.39
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38
Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH. Thromb Haemost (1995) 1.36
Unexplained thrombosis and factor V Leiden mutation. Lancet (1994) 1.28
Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation (1997) 1.28
Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract (2001) 1.28
Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur J Clin Invest (1999) 1.24
Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arterioscler Thromb Vasc Biol (2006) 1.23
Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol (1997) 1.21
Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med (1999) 1.19
Blood loss during repair of craniosynostosis. Br J Anaesth (1993) 1.19
Association between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease. Arterioscler Thromb Vasc Biol (2001) 1.18
Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest (1998) 1.18
Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. J Am Coll Cardiol (2000) 1.18
Vascular risk factors and morphometric data in cervical artery dissection: a case-control study. J Neurol Neurosurg Psychiatry (2009) 1.16
Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation (1996) 1.16
The P-selectin gene is highly polymorphic: reduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum Mol Genet (1998) 1.15
Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost (1997) 1.15
Chronic tonsillar herniation in Crouzon's and Apert's syndromes: the role of premature synostosis of the lambdoid suture. J Neurosurg (1995) 1.15
Polymorphisms of the human matrix gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol (2000) 1.14
Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation (1996) 1.14
Is the relationship between blood pressure and cardiovascular risk dependent on body mass index? Am J Epidemiol (1985) 1.13
Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. Eur J Epidemiol (1993) 1.11
Femoropopliteal stent placement: long-term results. Radiology (1992) 1.11
Hydrocephalus and craniosynostosis. J Neurosurg (1998) 1.10
[Prevalence and course of Wolf-Parkinson-White syndrome in a population of 138,048 subjects]. Ann Med Interne (Paris) (1985) 1.09
Atheroembolism in HIV-positive individuals. Lancet (1992) 1.09
Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. J Mol Cell Cardiol (1999) 1.09
Confirmation of associations between ion channel gene SNPs and QTc interval duration in healthy subjects. Eur J Hum Genet (2007) 1.08
Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet (1999) 1.07
Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. Am J Med (2001) 1.07
[Oxycephaly, a severe craniosynostosis. Apropos of a series of 129 cases]. Arch Pediatr (1997) 1.05
Protein C and protein S deficiencies. Semin Hematol (1997) 1.04
Association between migraine and endothelin type A receptor (ETA -231 A/G) gene polymorphism. Neurology (2001) 1.04
Occipital remodeling and suboccipital decompression in severe craniosynostosis associated with tonsillar herniation. Neurosurgery (1998) 1.04
Menopause-related changes in lipoproteins and some other cardiovascular risk factors. Int J Epidemiol (1990) 1.03
Associations between heart rate and other risk factors in a large French population. J Hypertens (1999) 1.02
A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol (2000) 1.02
Risk factors for early carotid atherosclerosis in middle-aged French women. Arterioscler Thromb (1991) 1.02
Should diastolic and systolic blood pressure be considered for cardiovascular risk evaluation: a study in middle-aged men and women. J Am Coll Cardiol (2001) 1.02
New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study. J Am Coll Cardiol (2001) 1.01
High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery. Br J Haematol (1998) 1.01
Hypercoagulable states in primary upper-extremity deep vein thrombosis. Arch Intern Med (2000) 1.01
[A new heart stimulator: the orthorhythmic pacemaker]. Presse Med (1971) 1.00
Met 358 to Arg mutation of alpha 1-antitrypsin associated with protein C deficiency in a patient with mild bleeding tendency. J Clin Invest (1992) 1.00
The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study. J Thromb Haemost (2004) 1.00
Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood (2001) 1.00